SCHEMBL6027802

SCHEMBL6027802

Clc1cnc(Cl)c(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30683717 0.75
SCHEMBL29828757 0.75
SCHEMBL29467490 0.75
SCHEMBL12902021 0.75
SCHEMBL4883086 0.75
SCHEMBL30927454 0.75
SCHEMBL1349372 0.75
SCHEMBL376483 0.75
SCHEMBL913739 0.75
SCHEMBL7350230 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4178962-B1 MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 NOVARTIS AG (CH) 2025-06-11 EP claimed
CN-119009136-A Pyrazinyl eutectic electrolyte with wide electrochemical stability window, and preparation method and application thereof 中国科学院长春应用化学研究所 2024-11-22 CN claimed
CN-115916786-A Manufacture of compounds and compositions for inhibiting SHP2 activity 诺华股份有限公司 2023-04-04 CN claimed
CN-113121457-B Synthesis process of Favipiravir intermediate 3, 6-dichloro-2-cyanopyrazine 白银康寓信生物科技有限公司 2021-11-30 CN claimed
CN-113121457-A Synthesis process of Favipiravir intermediate 3, 6-dichloro-2-cyanopyrazine 白银康寓信生物科技有限公司 2021-07-16 CN claimed
US-12441737-B2 Manufacture of compounds and compositions for inhibiting the activity of SHP2 NOVARTIS AG (CH) 2025-10-14 US disclosed
EP-4178962-B1 MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 NOVARTIS AG (CH) 2025-06-11 EP disclosed
US-20250179032-A1 HETEROCYCLIC INHIBITORS OF GLUT9 FOR TREATMENT OF DISEASE HORIZON THERAPEUTICS IRELAND DAC (IE) 2025-06-05 US disclosed
CN-112867718-B Manufacture of compounds and compositions for inhibiting SHP2 activity 诺华股份有限公司 2025-03-04 CN disclosed
CN-112839715-B Process for producing compound for inhibiting SHP2 activity 诺华股份有限公司 2024-12-03 CN disclosed
CN-119009136-A Pyrazinyl eutectic electrolyte with wide electrochemical stability window, and preparation method and application thereof 中国科学院长春应用化学研究所 2024-11-22 CN disclosed
CN-119013265-A GLUT9 heterocyclic inhibitors for the treatment of disease 爱尔兰好利恩治疗有限公司 2024-11-22 CN disclosed
EP-1341888-B1 LAUNDRY COMPOSITION UNILEVER PLC (GB) 2004-09-22 EP disclosed
EP-1341888-A1 LAUNDRY COMPOSITION UNILEVER PLC (GB) 2003-09-10 EP disclosed
US-20020155979-A1 Laundry composition UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2002-10-24 US disclosed
WO-2002048302-A1 LAUNDRY COMPOSITION UNILEVER PLC (GB) 2002-06-20 WO disclosed
EP-0915885-A1 PYRAZINE DERIVATIVES AND THEIR USE FOR MATERIAL AND PLANT PROTECTION BAYER AG (DE) 1999-05-19 EP disclosed
WO-1998004562-A1 PYRAZINE DERIVATIVES AND THEIR USE FOR MATERIAL AND PLANT PROTECTION BAYER AKTIENGESELLSCHAFT (DE) 1998-02-05 WO disclosed
US-4372328-A Fibrous material for tobacco smoke filter B.A.T. CIGARETTEN-FABRIKEN GMBH (DE) 1983-02-08 US disclosed
US-4299962-A Process for synthesizing 2-sulphanilamido-3-methoxypyrazine PIERREL S.P.A. (IT) 1981-11-10 US disclosed